Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 26921301000001114 | Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 38339201000001118 | Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Is a | Octreotide 500micrograms/1ml solution for injection ampoules 5 ampoule | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Is pack of | Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has active ingredient | Somatostatin | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has active ingredient | Octreotide | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has active ingredient | Octreotide acetate | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has active ingredient | Synthetic hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has AMP | Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Octreotide | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has specific active ingredient | Octreotide acetate | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules | Has basis of strength substance | Octreotide | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR